Testing effectiveness (Phase 2)Ended earlyNCT03091478
What this trial is testing
Pembrolizumab in Patients With Leptomeningeal Disease
Who this might be right for
Patients With Leptomeningeal Disease
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 13